B

Halozyme Therapeutics, Inc. HALO

NASDAQ
Recommendation
Dividend Power Score
Day's Range
$95.01$97.96
Latest Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
EPS (TTM)
My Lists My Alerts

09/30/2026 06/30/2026 03/31/2026 12/31/2025 09/30/2025
Net Income 485.42M 413.60M 348.84M 316.89M 595.49M
Total Depreciation and Amortization 128.58M 114.80M 101.34M 88.05M 81.79M
Total Amortization of Deferred Charges 8.67M 8.31M 7.91M 7.51M 7.40M
Total Other Non-Cash Items 391.83M 419.36M 405.26M 391.37M 43.78M
Change in Net Operating Assets -116.23M -137.47M -185.93M -152.26M -117.46M
Cash from Operations 898.27M 818.60M 677.42M 651.56M 611.00M
Capital Expenditure -12.39M -12.37M -9.76M -6.97M -8.60M
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -725.26M -725.26M -725.26M -725.97M --
Divestitures -- -- -- -- --
Other Investing Activities -48.73M 131.91M 276.75M 187.12M 234.05M
Cash from Investing -786.38M -605.72M -458.27M -545.81M 225.46M
Total Debt Issued 2.94B 1.47B 1.47B 1.47B --
Total Debt Repaid -1.67B -1.01B -1.01B -1.01B --
Issuance of Common Stock 31.81M 25.49M 21.83M 21.83M 21.27M
Repurchase of Common Stock -400.00M -371.61M -340.66M -342.37M -592.37M
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -409.21M -221.24M -221.24M -221.24M --
Cash from Financing 499.30M -110.75M -83.47M -85.17M -571.10M
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 611.18M 102.13M 135.68M 20.57M 265.35M